T 3041/19 (ERK inhibitors/MERCK) of 16.04.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T304119.20200416
- Date of decision
- 16 April 2020
- Case number
- T 3041/19
- Online on
- 29 April 2020
- Petition for review of
- -
- Application number
- 11836905.7
- IPC class
- A61K 45/06C07D 409/14C07D 417/14A61K 31/444C07D 413/14A61K 31/454A61K 31/415C07D 405/14C07D 471/04C07D 401/14A61K 31/4545A61K 31/5377
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- NOVEL COMPOUNDS THAT ARE ERK INHIBITORS
- Applicant name
- Merck Sharp & Dohme Corp.
- Opponent name
- -
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108 (2007)European Patent Convention R 99(2) (2007)European Patent Convention R 101(1) (2007)
- Keywords
- Admissibility of appeal - missing statement of grounds
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is rejected as inadmissible.